Status:
UNKNOWN
Changes in Viral Load in COVID-19 After Probiotics
Lead Sponsor:
Hospital de Sagunto
Collaborating Sponsors:
Biopolis S.L.
Laboratorios Heel España
Conditions:
COVID-19
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The main objective of the study is to evaluate the capacity of a novel nutritional supplement intervention including strains from the species Bifidobacterium longum, Bifidobacterium animalis subsp. La...
Detailed Description
1. Study hypothesis: Through the administration of specific probiotics, the immune response against the coronavirus COVID-19 could be stimulated, being able to decrease its viral load and secondary sy...
Eligibility Criteria
Inclusion
- Patients over 18 years of age admitted to the Internal Medicine Unit of Sagunto Hospital, for illness due to infection secondary to COVID-19 during the study period.
- To be willing and able to sign the informed consent to participate
Exclusion
- Not meeting any of the inclusion criteria.
- Present allergy to any of the components of the nutritional supplement Gasteel Plus.
- Not being able to ingest anything by mouth, either by dysphagia or by prescription.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04666116
Start Date
April 1 2020
End Date
February 1 2021
Last Update
December 16 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Sagunto
Sagunto, Valencia, Spain, 46520
2
Hospital de Sagunto
Valencia, Spain, 46520